TrialStudy to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)
Trial details
- Registry ID
- NCT04270682
- Phase
- Phase 3
Drug research
Rescue Medication CDCA 250 mg TID
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)NCT04270682 | MIRM | Phase 3 | Completed | 2023-07-13Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |